The growth of this market is majorly driven by factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies. However, factors such as the high cost of instruments and laboratory documentation systems are expected to restrain the growth of this market during the forecast period.
Based on product service, the market is segmented into instruments, consumables, and software services. Instruments formed the largest product segment in this market owing to technological advancements and the high price of mass spectroscopy and crystallography instruments (as compared to consumables).
Download PDF Brochure With Latest Edition @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=898
Monoclonal antibodies accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases.
The rational protein design segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the increasing use and continuous upgrades of bioinformatics platforms and software for protein analysis.
Based on end user, the market is segmented into biopharmaceutical companies, contract research organizations, and academic research institutes. The biopharmaceutical companies segment accounted for the largest share of the market in 2019. This is because protein engineering products are widely used for drug discovery and development by biopharmaceutical companies, as they help in designing models to develop a broad range of protein-based drugs.
The large share of the North American market is attributed to the presence of well-established CROs, rising RD expenditure, and the availability of the latest techniques and instruments for drug discovery research in the region. Also, the rising adoption of biologic drugs such as monoclonal antibodies, erythropoietin, and interferons for the treatment of chronic diseases is a major factor driving the growth of the North American market.
The major companies operating in the global protein engineering market include Thermo Fisher Scientific (US), Danaher Corporation (US), Agilent Technologies (US), and Bio-Rad Laboratories (US).
To get a free sample report, Click here: https://www.marketsandmarkets.com/requestsampleNew.asp?id=898
Protein Type
- Monoclonal Antibodies
- Erythropoietin
- Interferons
- Vaccines
- Colony-stimulating Factors
- Growth Hormones
- Coagulation Factors
#Protein Engineering Market #Protein Engineering #Protein #Health #Fitness
Lentil Protein Market: IntroductionA recent study published by Transparency Market Research on the global lentil protein market covers global industry analysis and opportunity assessment for 2020-2030.
Complete revenue generated from the global lentil protein market is valued at ~US$ 112 Mn in 2020 that is anticipated to expand at a CAGR of 4.8%, to reach ~US$ 181 Mn by 2030.Request a Sample –https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=78116Immense Market Potential for Sports NutritionThere is an increasing consumer awareness for lentil protein among health-conscious end users, especially those consumers who consume sports nutrition products on a daily basis.
Moreover, several consumers are switching to a more leisure lifestyle, and focusing on boosting their health performance.
Lentil protein has a positive perception among consumers regarding health benefits, and this a major factor driving the market in regions such as the U.S., the U.K., Brazil, Germany, and Japan.
Hence, manufacturers have opportunities for developing new products with lentil protein, which are the vanguard of the plant protein vertical in the nutrition industry.Request for covid19 impact analysis –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=78116Protein Fortification and Standardization Propelling MarketProtein fortification is the supplementation of regular food products with texturized vegetable protein giving the product a 'high-protein' label.
Customer preference for these types of food products is a result of several factors, including increasing incidences of lifestyle-related disorders, along with weight management.
The global Frozen Food Market size is expected to value at USD 360.36 billion by 2024.
The market is subject to witness a substantial growth due to the changing lifestyle patterns, shifting preferences among consumers towards ready-to-cook meals, increasing demand for convenience food, and growing focus towards hygienic food products.
Frozen food products are able to retain maximum vitamins and minerals.The freezing allows longer shelf life for the food products and limits any form of microbial growth that leads to food spoilage.
In addition, increasing penetration by e-commerce retail stores is expected to fuel the growth of frozen food industry in the upcoming years.
Increasing demand form staple food products from developed economies across the globe is propelling market growth as well, in the recent years.
Increasing demand for frozen fruits and vegetables from developed and developing economies is expected to positively affect market performance of frozen food industry in the upcoming years.
Transparency Market Research (TMR) has published a new report titled, ‘Nitinol Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global Nitinol medical devices market was valued at US$ 14,571.7 Mn in 2018 and is projected to expand at a CAGR of 8.5% from 2019 to 2027.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1685 OverviewNitinol is an unique class of shape-memory alloy that is made of nickel titanium.
Nitinol properties include the shape-memory effect, super elasticity, and high damping capability.
These technical properties of nitinol shape-memory alloy can be modified to a large extent by changes in composition, heat treatment, and mechanical working.Some of the major properties of nitinol include high fatigue strength, nonmagnetic, high power/weight ratio, corrosion resistance, heat resistance, and biocompatible.Nitinol is used in cardiovascular stents, kink resistant guide wires, minimally invasive surgical tools, and self-locking orthopedic devices.
).North America dominated the global nitinol medical devices market in 2018 and the trend is anticipated to continue during the forecast period.
Increasing adoption of technological advanced products and increasing prevalence of peripheral artery disease has contributed to dominant share of the region in global market.Asia Pacific is likely to be a highly lucrative market for nitinol medical devices and it is expected to expand at a high CAGR during the forecast periodRequest Customization on Nitinol Medical Devices Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=1685 Increased Clinical Application of Nitinol Based Products in Medical Procedures to Drive MarketUsage of nitinol in the medical industry has increased due to demand for minimally invasive procedures utilizing novel instruments and implants.
